Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
50.10
-0.33 (-0.66%)
Dec 23, 2024, 3:29 PM EST - Market open
Azenta Market Cap
Azenta has a market cap or net worth of $2.28 billion as of December 23, 2024. Its market cap has decreased by -43.29% in one year.
Market Cap
2.28B
Enterprise Value
1.83B
1-Year Change
-43.29%
Ranking
Category
Stock Price
$50.10
Market Cap Chart
Since December 1, 1998, Azenta's market cap has increased from $156.00M to $2.28B, an increase of 1,363.90%. That is a compound annual growth rate of 10.84%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 2.77B | -38.42% |
Dec 29, 2023 | 4.50B | 3.18% |
Dec 30, 2022 | 4.37B | -43.01% |
Dec 31, 2021 | 7.66B | 53.08% |
Dec 31, 2020 | 5.00B | 65.34% |
Dec 31, 2019 | 3.03B | 63.89% |
Dec 31, 2018 | 1.85B | 11.18% |
Dec 29, 2017 | 1.66B | 41.81% |
Dec 30, 2016 | 1.17B | 62.52% |
Dec 31, 2015 | 720.70M | -15.39% |
Dec 31, 2014 | 851.80M | 22.12% |
Dec 31, 2013 | 697.50M | 30.67% |
Dec 31, 2012 | 533.80M | -21.43% |
Dec 30, 2011 | 679.40M | 15.25% |
Dec 31, 2010 | 589.50M | 6.85% |
Dec 31, 2009 | 551.70M | 49.51% |
Dec 31, 2008 | 369.00M | -63.14% |
Dec 31, 2007 | 1.00B | -7.76% |
Dec 29, 2006 | 1.09B | 91.38% |
Dec 30, 2005 | 567.10M | -26.06% |
Dec 31, 2004 | 767.00M | -13.40% |
Dec 31, 2003 | 885.70M | 112.40% |
Dec 31, 2002 | 417.00M | -48.51% |
Dec 31, 2001 | 809.90M | 67.58% |
Dec 29, 2000 | 483.30M | 16.26% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Privia Health Group | 2.41B |
Tandem Diabetes Care | 2.36B |
Addus HomeCare | 2.36B |
NewAmsterdam Pharma Company | 2.36B |
Beam Therapeutics | 2.31B |
Ardent Health Partners | 2.29B |
Centessa Pharmaceuticals | 2.26B |
Iovance Biotherapeutics | 2.25B |